2018 update on intravitreal injections: euretina expert consensus recommendations

A Grzybowski, R Told, S Sacu, F Bandello… - …, 2018 - karger.com
Intravitreal injections (IVI) have become the most common intraocular procedure worldwide
with increasing numbers every year. The article presents the most up-to-date review on IVI …

Liposomes for intravitreal drug delivery: a state of the art

A Bochot, E Fattal - Journal of Controlled Release, 2012 - Elsevier
Intravitreal administration of drugs has raised a large interest during the last two decades
improving the treatment of infectious diseases of the posterior segment of the eye or …

Intraocular pressure monitoring post intravitreal steroids: a systematic review

W Kiddee, GE Trope, L Sheng, L Beltran-Agullo… - Survey of …, 2013 - Elsevier
The use of intravitreal (IVT) corticosteroids for treatment of posterior segment diseases has
increased significantly over the last decade. A commonly recognized complication of IVT …

The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis

VA de Vries, FL Bassil, WD Ramdas - Scientific Reports, 2020 - nature.com
The number of eye diseases treated with intravitreal injections is increasing. Obviously, an
injection of fluid into the eye results in an increase of intraocular pressure (IOP), the main …

Short-term intraocular pressure changes immediately after intravitreal injections of anti–vascular endothelial growth factor agents

JE Kim, AV Mantravadi, EY Hur, DJ Covert - American journal of …, 2008 - Elsevier
PURPOSE: To assess short-term trends and the need to monitor intraocular pressure (IOP)
changes immediately after intravitreal injections of ranibizumab, bevacizumab, pegaptanib …

Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections

RA Adelman, Q Zheng, HR Mayer - Journal of ocular pharmacology …, 2010 - liebertpub.com
Purpose: To study ocular hypertension (OHT) following intravitreal injections of
bevacizumab and/or ranibizumab in patients with age-related macular degeneration (AMD) …

Management of ischemic optic neuropathies

SS Hayreh - Indian journal of ophthalmology, 2011 - journals.lww.com
Ischemic optic neuropathies (IONs) consist primarily of two types: anterior ischemic optic
neuropathy (AION) and posterior ischemic optic neuropathy (PION). AION comprises arteritic …

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy

D Pożarowska, P Pożarowski - Central European Journal of …, 2016 - termedia.pl
Angiogenesis is a clue process for tissue development and function, both in normal and
pathological conditions. This process is regulated by multiple molecular systems. One of the …

A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections

MI Van der Reis, EC La Heij, Y De Jong-Hesse… - Retina, 2011 - journals.lww.com
Background: Intravitreal ranibizumab and pegaptanib are registered for neovascular age-
related macular degeneration. No formal safety study has been conducted for intravitreal …

Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections

QV Hoang, LS Mendonca, KE Della Torre, JJ Jung… - Ophthalmology, 2012 - Elsevier
PURPOSE: We assessed the frequency and predictive factors related to intraocular pressure
(IOP) elevation in neovascular age-related macular degeneration (AMD) patients …